Schizophrenia trials in Serbia

In Serbia 9 Also abroad 473

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Where
Belgrade, Niš, Novi Sad
Age
5 years to 17 years
People
300 worldwide
Run by
Intra-Cellular Therapies, Inc.
See details and how to joinNCT06229210 · EU 2023-507068-38-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Where
Belgrade, Kovin, Kragujevac, Niš, Novi Kneževac
Age
55 years and over
People
370 worldwide
Run by
Intra-Cellular Therapies, Inc.
See details and how to joinNCT06540833
Phase 3Taking people
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Where
Belgrade, Gornja Toponica, Kovin, Kragujevac, Novi Sad
Age
55 years to 90 years
People
406 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Where
Kragujevac
Age
55 years to 90 years
People
300 worldwide
Run by
MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00
Phase 3Taking people
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Where
Belgrade, Gornja Toponica, Kragujevac
Age
18 years to 65 years
People
284 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT07105098 · EU 2025-521215-39-00
Phase 3Taking people
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Where
Belgrade, Gornja Toponica, Kragujevac
Age
18 years to 65 years
People
600 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT07114874 · EU 2025-521216-19-00
Phase 3Taking people
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Where
Gornja Toponica, Kragujevac
Age
18 years to 65 years
People
560 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT07227818
Phase 4Taking people
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Where
Belgrade
Age
16 years to 70 years
People
2,500 worldwide
Run by
Parnassia Groep
See details and how to joinNCT05656469 · EU 2023-509680-25-00
Phase 3Taking people
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Where
Belgrade, Novi Sad
Age
13 years to 17 years
People
330 worldwide
Run by
Gedeon Richter Plc.
See details and how to joinNCT03817502 · EU 2024-513194-44-00